NasdaqCM:SNDLPharmaceuticals
SNDL FY 2025 EPS Loss Renews Doubts On Profitability Narrative
SNDL FY 2025 Results: Revenue Holds Steady While Losses Persist
SNDL (NasdaqCM:SNDL) has just posted its latest numbers, with third quarter FY 2025 revenue at C$244.2 million and basic EPS at a loss of C$0.05, setting the tone for a year where profitability remains under pressure. The company has seen quarterly revenue move from C$257.7 million in Q4 2024 to C$204.9 million in Q1 2025, then sit around C$244 million through Q2 and Q3 2025, while EPS has swung between a loss of C$0.25 in Q4...